Phlexglobal has announced the launch of a specialist consulting group along with the appointment of a head of division.
The new eTMF Consulting Group, led by Jane Clarke who joins Phlexglobal from Wyeth, will provide the expertise for companies in all aspects of records management, with a specific focus on TMFs, electronic TMFs (eTMFs) and the migration from paper to electronic.
Phlexglobal has has focused on the support and development of eTMFs for the past eight years. During this time the company has gained experience, leading to the launch of the eTMF Consulting Group.
In addition to running the new Group, Jane will also be responsible for enhancing the functionality of Phlexglobal’s bespoke eTMF solution – PhlexEview – drawing on customer requirements and Phlexglobal’s vision for the future of eTMFs.
During her time at Wyeth, Jane gained experience in the development, integration and support of a variety of clinical research systems - CTMS, EDC, ePRO, eTMF and IVR -through the creation of a dedicated division. Jane also successfully implemented EDC resulting in a 90 per cent take-up in 11 months and the transition from a custom-built to a commercial EDC solution. Jane is a keynote speaker at the 9th Annual Partnerships in Clinical Trials Conference in Vienna in November 2010.
For further information on Phlexglobal’s eTMF solutions, visit the website at www.phlexglobal.com .
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Zenocutuzumab Shows Durable Efficacy in NRG1 Fusion-Positive Cancers in Phase II eNRGy Trial
February 13th 2025The Phase II eNRGy trial showed durable antitumor activity with zenocutuzumab (Bizengri) in patients with NRG1 fusion–positive cancers, particularly non-small cell lung cancer and pancreatic cancer.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.